Over expression of IGF-1/IGF-1R has been found to result in the initiation of prostate cancer (Cox et al., 2009) with the PI3/Akt and Ras/Raf/MEK/MAPK being the major pathways associated with the activation of the same (Ozkan, 2011). Here, IGF1 is linked to prostate carcinoma.